drugset / Trial / NCT06663878
An Exploratory Study to Evaluate the Tolerability and Safety of MWAV201 in Subjects With Wilson Disease
Not yet recruiting
9 enrolled
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Mabwell (Shanghai) Bioscience Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to evaluate the tolerability and safety of MWAV201 in patients with Wilson disease.
Timeline
- Start
- 2024-10
- Primary completion
- 2026-03
- Completion
- 2031-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MWAV201 | Unknown | — | Intravenous |